Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TL118 in Solid Tumors With NTRK Gene Fusions
NCT06010342Phase 2Recruiting
- Sponsor
- SuZhou Teligene
- Start
- Mar 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of TL118 in solid tumor, sponsored by SuZhou Teligene. Started Mar 2023; status: recruiting.
02
Drugs
TL118
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06010342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06010342.